Latest Happenings

Repurposing RNA Sequencing for Discovery of RNA Modifications in Clinical Cohorts. (Sci Adv, Aug 2021)

Kar-Tong Tan 1 2 3, Ling-Wen Ding 4, Chan-Shuo Wu 1, Daniel G Tenen 5 6, Henry Yang 5 7 Affiliations 1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. 2Biological and Biomedical Sciences Program, Division of Medical Sciences, Harvard Medical …

Repurposing RNA Sequencing for Discovery of RNA Modifications in Clinical Cohorts. (Sci Adv, Aug 2021) Read More »

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation. (Genome Biol, Jun 2021)

Nisha Padmanabhan 1, Huang Kie Kyon # 1, Arnoud Boot # 2, Kevin Lim 1, Supriya Srivastava 3, Shuwen Chen 4, Zhiyuan Wu 5, Hyung-Ok Lee 6, Vineeth T Mukundan 7, Charlene Chan 7, Yarn Kit Chan 1, Ong Xuewen 1, Jason J Pitt 7, Zul Fazreen Adam Isa 1, Manjie Xing 1, Ming Hui Lee 1, Angie Lay Keng Tan 1, Shamaine Ho Wei Ting 1, Micah …

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation. (Genome Biol, Jun 2021) Read More »

Mitochondria transfer from early stages of erythroblasts to their macrophage niche via tunnelling nanotubes. (Br J Haematol, Jun 2021)

Chong Yang 1, Mitsuhiro Endoh 1 2, Darren Q Tan 1, Ayako Nakamura-Ishizu 1 3, Yuji Takihara 1, Takayoshi Matsumura 1, Toshio Suda 1 4 Affiliations 1Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 2Department of Pluripotent …

Mitochondria transfer from early stages of erythroblasts to their macrophage niche via tunnelling nanotubes. (Br J Haematol, Jun 2021) Read More »

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma. (Cancer Res, May 2021)

Phyllis S Y Chong # 1, Jing Yuan Chooi # 2, Julia S L Lim 2 3, Sabrina Hui Min Toh 3, Tuan Zea Tan 3, Wee-Joo Chng 1 3 4 Affiliations 1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. …

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma. (Cancer Res, May 2021) Read More »